Completed OBSERVATIONAL NCT03872882

Accuscreen Equipment Evaluation For Newborn Hearing Screening

Equipment Evaluation for Newborn Hearing Screening. A Randomised Comparison of Screen Outcome Between Standard Madsen 'Accuscreen New' and Madsen 'Accuscreen New' With Fast Refer Disabled and Increased Test Time

Sponsor: GN Otometrics

Conditions Hearing Loss

Updated 5 times since 2019 Last updated: Nov 6, 2019 Started: Mar 22, 2017 Primary completion: Dec 13, 2017 Completion: Dec 13, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03872882, this observational or N/A phase trial focuses on Hearing Loss and remains completed. Sponsored by GN Otometrics, it has been updated 5 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Dec 2019 — Jan 2021 [monthly]

Completed
Apr 2019 — Dec 2019 [monthly]

Completed

First recorded

Mar 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

GN Otometrics
Julie Dawson
University of East Anglia

Data source: Norfolk and Norwich University Hospitals NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Norwich, United Kingdom